Experimental gel aims to heal fragile skin in 'Butterfly Children'
NCT ID NCT06594393
Summary
This study is testing a gel called TCP-25 to see if it helps heal skin wounds in people with epidermolysis bullosa (EB), a condition that causes extremely fragile, blistering skin. In the trial, each participant will have two similar wounds treated—one with the TCP-25 gel and one with a placebo gel—to compare how well they heal. The main goal is to see if the TCP-25 gel is safe and reduces the size of the open wounds over 8 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Andreas Syngros Hospital of Veneral & Dermatological Diseases
RECRUITINGAthens, Greece
-
Hopital St Louis
RECRUITINGParis, France
Contact
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, Spain
Contact Email: •••••@•••••
-
Hospital Of Skin And Venereal Diseases of Thessaloniki
RECRUITINGThessaloniki, Greece
-
Hospital Univ La Paz
RECRUITINGMadrid, Spain
-
University hospital
NOT_YET_RECRUITINGLund, Skåne County, 23735, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.